DSP Nifty Healthcare ETF

Download

Benchmark: NIFTY_1D_Rate_Index

View Basket

LumpsumView performance details

Return:

Annualized

Absolute

This fund

NIFTY_1D_Rate_Index

NIFTY 50 TRI

Total AUM

₹10.63 crores as of Sep 30, 2025

Age of Fund

1 years 8 months since Feb 01, 2024

Expense Ratio

0.2%
as of Jul 24, 2025

Exit Load

Nil

Goal of Investment

Capital Growth & Income

Ideal holding period

10 Years+

Indian (99.9%)

Large Cap	73.3%
Mid Cap	24.1%
Small Cap	2.5%

Holdings
Sectors

Top Holdings	Weight %
Sun Pharmaceutical Industries Limited	17.8 %
Cipla Limited	8.9 %
Max Healthcare Institute Limited	8.8 %
Apollo Hospitals Enterprise Limited	7.9 %
Dr. Reddy's Laboratories Limited	7.9 %
Divi's Laboratories Limited	7.7 %
Fortis Healthcare Limited	5.3 %
Lupin Limited	4.9 %
Torrent Pharmaceuticals Limited	4.0 %
Laurus Labs Limited	3.5 %
Alkem Laboratories Limited	3.2 %
Aurobindo Pharma Limited	3.2 %
Glenmark Pharmaceuticals Limited	3.1 %
Mankind Pharma Limited	2.9 %
Zydus Lifesciences Limited	2.6 %
Biocon Limited	2.2 %
IPCA Laboratories Limited	2.0 %
Abbott India Limited	1.6 %
Piramal Pharma Limited	1.3 %
Syngene International Limited	1.3 %
View All Holdings	99.9 % 76.6 %

Sectors Weight %

Pharmaceuticals & Biotechnology 76.6 %

Sun Pharmaceutical Industries Limited 17.8 %

Cipla Limited 8.9 %

Dr. Reddy's Laboratories Limited 7.9 %

Divi's Laboratories Limited 7.7 %

Lupin Limited 4.9 %

Torrent Pharmaceuticals Limited 4.0 %

Laurus Labs Limited 3.5 %

Alkem Laboratories Limited 3.2 %

Aurobindo Pharma Limited 3.2 %

Glenmark Pharmaceuticals Limited 3.1 %

Mankind Pharma Limited 2.9 %

Zydus Lifesciences Limited 2.6 %

Biocon Limited 2.2 %

IPCA Laboratories Limited 2.0 %

Abbott India Limited 1.6 %

Piramal Pharma Limited 1.3 %

Healthcare Services 23.3 %

Max Healthcare Institute Limited 8.8 %

Apollo Hospitals Enterprise Limited 7.9 %

Fortis Healthcare Limited 5.3 %

Syngene International Limited 1.3 %

Expand All

99.9 %

Indian (0.1%)

Credit rating profile	Weight %
Cash & Equivalent	0.1 %

Instrument break-up	Weight %
TREPS	0.1 %

Top Holdings	Weight %
TREPS / Reverse Repo Investments	0.1 %
Cash & cash equivalents	0.0 %
	0.1 %

Indicators

Portfolio turnover ratio

0.32 last 12 months

Tracking Error

16.85 %

Tracking Error (Abs.)

1.066 %

View Top Group Holdings

Compare Performance

Returns Highlights
Rolling Returns

Historical Returns (As per SEBI format)as of with investment of₹10,000

	This fund		NIFTY_1D_Rate_Index ^{^}		NIFTY 50 TRI ^#		Tracking difference
	CAGR	Current Value	CAGR	Current Value	CAGR	Current Value

Income distribution Cum Capital Withdrawal (IDCW) Distributed

Record Date	Face Value	IDCW per unit	NAV Before	NAV After

Chart type:

Returns RangesStatistics

Invested Amount

₹

Rolling period

Funds	Minimum	Median	Maximum	% times -ve returns	% times returns > 7%

Date of allotment: Feb 01, 2024.

Period for which fund's performance has been provided is computed based on last day of the month-end preceding the date of advertisement

Since inception returns have been calculated from the date of allotment till June 30, 2021

Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments

Pursuant to payments of Income Distribution cum Capital Withdrawal, the NAV of the IDCW option(s) of Schemes would fall to the extent of payout, and statutory levy, if any.

^ Fund Benchmark # Standard Benchmark

Scheme disclaimers

Fund Details

Things to know before you invest

What is in DSP Nifty Healthcare ETF?

High Government's Healthcare Spending 2.5% of the budget has been forecasted by the Indian Government for healthcare spending as % of Gross Domestic Product (GDP) by FY25. More funds mean a healthier nation, which, also benefits the businesses in this sector.
8% CAGR increase in Foreign Direct Investments (FDIs) in healthcare from FY13 to FY23. Within the broader level healthcare sector, FDI flows have increased in drugs & pharmaceuticals, hospitals & diagnostic centres, and medical & surgical appliances in India.
Remarkable Past performance The healthcare sector has the potential to provide reasonably high returns with events of short-term underperformance as well. However, since 2008, the Nifty Healthcare TRI has largely delivered relatively better CAGR of ~13% vs ~10% by Nifty 500 TRI.
Rising Insurance Penetration US$ 222 Billion reach expected in the Indian Insurance market by the year 2026. Many Indians have started to recognise the importance of owning health insurance, hence, the business opportunities have a potential to grow.
No Stock Selection Hassle Don't stress about picking individual stocks. The Healthcare Index covers it all from diversified themes like pharmaceuticals, hospitals, pathology, healthcare research analytics & technology. It adjusts or rebalances every 6 months i.e. semi-annually to represent the top 20 stocks (companies from healthcare sector) based on free float market cap from the Nifty 500 universe.

Who should invest in DSP Nifty Healthcare ETF?

Consider this fund if you
- If you value low-cost investing ideas.
- If you are okay with the returns not beating the respective Index the ETF is tracking.
- If you can stay invested for more than 5 years.
- If you can time the sector based on market dynamic.

Rethink before you invest

Expect short term return fluctuations, especially during periods of market volatility?.
Being a single sector based fund, DSP Nifty Healthcare ETF comes with high risk as well.

Fund managers:

Anil Ghelani

Managing Since February 2024

arrow_forwardSee funds managed by him

Managing Since February 2024

arrow_forwardSee funds managed by him

Diipesh Shah

Managing Since February 2024

arrow_forwardSee funds managed by him

Managing Since February 2024

arrow_forwardSee funds managed by him

Anil has been working with DSP Group since 2003 and is currently Head of Passive Investments & Products. Previously, he served as the Business Head & Chief Investment Officer at DSP Pension Fund Managers and prior to that leading the Risk and Quantitative Analysis team at DSP Mutual Fund responsible for monitoring of portfolio risk and buy-side credit research on companies across various sectors.
He also worked at IL&FS Asset Management Company and at S.R. Batliboi a member firm of EY. He is currently serving in volunteer capacity as a Director and Vice Chairman of the CFA Society India.
Anil is a CFA Charter Holder (CFA Institute USA), Chartered Accountant (ICAI India) and holds a Bachelor of Commerce degree (University of Mumbai).

Sr. No.	Scheme Name	Managing since	Period
Period for which fund's performance has been provided is computed based on last day of the month-end preceding the date of advertisement Different plans shall have a different expense structure. The performance details provided herein are of regular plan. Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments

Sr. No.

Scheme Name

Managing since

Period

1 Years

3 Years

5 Years

Scheme return (%)

Benchmark return (%)

Scheme return (%)

Benchmark return (%)

Scheme return (%)

Benchmark return (%)

Period for which fund's performance has been provided is computed based on last day of the month-end preceding the date of advertisement

Different plans shall have a different expense structure. The performance details provided herein are of regular plan.

Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments

Diipesh has a total work experience of Over 20 years. He is working with DSP from September 2019 as a Dealer for ETF and Passive Investments. Now he is also Fund Manager of various schemes of DSP Mutual Fund.
Diipesh has also worked with JM Financial Institutional Broking Limited, Centrum Boking Limited, IDFC Securities Limited and Kotak Securities Limited as Institutional Equity Sales Trading.
He is a Chartered Accountant (ICAI India) and also holds a Bachelor of Commerce Degree.

Sr. No.	Scheme Name	Managing since	Period
Period for which fund's performance has been provided is computed based on last day of the month-end preceding the date of advertisement Different plans shall have a different expense structure. The performance details provided herein are of regular plan. Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments

Sr. No.

Scheme Name

Managing since

Period

1 Years

3 Years

5 Years

Scheme return (%)

Benchmark return (%)

Scheme return (%)

Benchmark return (%)

Scheme return (%)

Benchmark return (%)

Period for which fund's performance has been provided is computed based on last day of the month-end preceding the date of advertisement

Different plans shall have a different expense structure. The performance details provided herein are of regular plan.

Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments

Investment Objective

The Scheme seeks to provide returns that, before expenses, correspond to the total return of the underlying index (Nifty Healthcare TRI), subject to tracking errors.
There is no assurance or guarantee that the investment objective of the scheme will be achieved.

Fund Type

Exchange Traded Fund – Thematic

An open ended scheme replicating/ tracking Nifty Healthcare Index

Riskometer

Level of Risk in the Scheme

View details

Other Information

NSE Symbol/Scrip Code HEALTHADD
ISIN INF740KA1UF4
Bloomberg Code DHEALTH
Minimum Investment Through Stock Exchange - 1 Unit & in multiples thereof.

Tax Implications (Applies to redemptions or transfers made on or after April 1, 2025)

Taxation category - Equity Oriented Fund Sub Category - Equity ETF

Holding period	Capital gain type	Applicable tax rate
More than 12 months	Long term	12.5 %
12 months or less	Short term	20 %

Mutual fund taxation is based on the fund’s taxation category, sub-category, and holding period. The applicable tax rates are subject to prevailing tax laws, including surcharges, cess, and exemptions. Please consult a tax advisor for personalized guidance. View detailed tax guide

NSE Disclaimer: It is to be distinctly understood that the permission given by NSE should not in any way be deemed or construed that the Scheme Information Document has been cleared or approved by NSE nor does it certify the correctness or completeness of any of the contents of the Draft Scheme Information Document. The investors are advised to refer to the Scheme Information Document for the full text of the 'Disclaimer Clause of NSE'

BSE Disclaimer: It is to be distinctly understood that the permission given by BSE Limited should not in any way be deemed or construed that the SID has been cleared or approved by BSE Limited nor does it certify the correctness or completeness of any of the contents of the SID. The investors are advised to refer to the SID for the full text of the 'Disclaimer clause of the BSE Limited'.